Home Newsletters Extracellular Matrix News Pretreatment Tumor Immune Microenvironment Predicts Clinical Response and Prognosis of Muscle-Invasive Bladder...

Pretreatment Tumor Immune Microenvironment Predicts Clinical Response and Prognosis of Muscle-Invasive Bladder Cancer in the Neoadjuvant Chemotherapy Setting

0
Scientists examined the relationship between the tumor microenvironment and the clinical efficacy of neoadjuvant chemotherapy in patients with cT2-4aN0M0 bladder cancer using multiplex fluorescence immunohistochemistry.
[British Journal of Cancer]
7992332 {7992332:BBBBBBBB} apa 50 1 168982 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
Abstract
Exit mobile version